BofA Securities analyst Sachin Jain reiterated a Neutral rating and DKK375.00 price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Intl Ratings

Morgan Stanley Reiterates Overweight Rating on Eli Lilly (LLY)August 8, 2025 7:10 AM